雷志淏 Zhihao Lei, FRSS

雷志淏 Zhihao Lei, FRSS

Research Fellow

Publications

You can also find my articles on my Google Scholar profile.

Journal articles

  1. Lei, Z. (2025). Addressing the indirect health burden of COVID-19. BMJ, 390, r1268. [Link]
  2. Lei, Z. (2025). A comprehensive statistical analysis of COVID-19 trends: Global and United States insights through ARIMA, regression, and spatial models. Microbes & Immunity, 2(3), 108–129. [Link]
  3. Dong, B., Xu, H., Tang, N., Jiang, M., Lei, Z., & Han, Y. (2025). Analysis of key factors and equity in influenza vaccination among Chinese adults: Evidence from a large national cross-sectional survey. Frontiers in Public Health, 13, 1601577. [Link]
  4. Jin, L., Lei, Z., Lin, P., Ma, C., Zhang, W., Zhou, J., Meng, S., Jiang, Z., Bu, Y., Xu, Y., Wei, N., Hsu, T., Qin, G., & Qiu, H. (2024). Deep Learning with Evolutionary Scale Modeling to discover Antibiotic-Resistance Drug against Klebsiella Pneumoniae. bioRxiv. [Link]
  5. Lin, P., Zhou, J., Meng, S., Lei, Z., Jin, L., Qiu, H., Xu, Y., Hsu, T., Bu, Y., Qin, G., & Zhang, W. (2025). Deep Learning-Driven Discovery of Potential Antibiotic-Resistance Drugs Targeting Klebsiella Pneumoniae. bioRxiv. [Link]
  6. Lei, Z. (2026). “Efficacy or illusion?” Interpreting null results in the rifaximin trial. Journal of Hepatology, 84(2), e69. [Link]
  7. Lei, Z. (2026). Re: Oliver Wiseman, Daron Smith, Kathryn Starr, et al. The PUrE Randomised Controlled Trial 1: Clinical and Cost Effectiveness of Flexible Ureterorenoscopy and Extracorporeal Shockwave Lithotripsy for Lower Pole Stones of ≤10 mm. European Urology, 89(1), e24–e25. [Link]
  8. Lei, Z. (2025). Rethinking End Points in Modern Oncology Trials—Beyond the P Value. JAMA Oncology, 11(12), 1553-1554. [Link]
  9. Lei, Z. (2025). Evidence Without Impact?—Rethinking Home Visiting at Scale. JAMA Pediatrics, 179(12), 1363–1364. [Link]
  10. Lei, Z. (2025). “Surrogates Without Substance?” Questioning the Evidence for Histologic Improvement With HTD1801. Clinical and Molecular Hepatology. Advance online publication. [Link]
  11. Lei, Z. (2025). From Benchmark to Bedside: Can Multimodal AI Withstand Real-World Dermatology? British Journal of Dermatology, 193(6), 1265. [Link]
  12. Lei, Z. (2026). “Policy or Perception?”: Rethinking the Influence of Hospital Guidelines on ICU Decisions. Chest, 169(1), e35–e36. [Link]
  13. Lei, Z. (2025). Comment on “Polygonati Rhizoma Prevents Glucocorticoid-Induced Growth Inhibition of Muscle via Promoting Muscle Angiogenesis Through Deoxycholic Acid” by Shi et al. Journal of Cachexia, Sarcopenia and Muscle, 16(5), e70074. [Link]
  14. Lei, Z. (2025). Fully covered self-expandable metal stents for type II perforations: Better outcomes or just better statistics? Gastrointestinal Endoscopy, 102(6), 930–931. [Link]
  15. Lei, Z. (2025). “From Genes to Drugs?” Reassessing the Translational Boundaries of APOC3 Genetic Modelling for Coronary Heart Disease. European Journal of Preventive Cardiology. Advance online publication. [Link]
  16. Lei, Z. (2025). Letter Re: Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor. European Journal of Cancer, 229, 115753. [Link]
  17. Lei, Z. (2025). No Effect or No Power? Reassessing Remote Ischaemic Pre-conditioning Evidence in Intermittent Claudication. European Journal of Vascular and Endovascular Surgery. Advance online publication. [Link]
  18. Lei, Z. (2025). “Compressed design, inflated conclusions?” A cautionary note on vaporized DMT trials. European Neuropsychopharmacology, 99, 13. [Link]
  19. Lei, Z. (2025). The Illusion of Absence: Rethinking Persistent Critical Illness in Low- and Middle-Income Countries. Critical Care Medicine, 53(11), e2395–e2396. [Link]
  20. Lei, Z. (2025). “Too small to succeed?” Rethinking efficacy claims in a solriamfetol trial for ME/CFS. Journal of Psychopharmacology. Advance online publication. [Link]
  21. Lei, Z. (2025). “No Difference or Missed Difference?” Revisiting Functional Gains in Low Back Pain. Annals of Emergency Medicine, 86(6), 704–705. [Link]
  22. Lei, Z. (2025). Post Hoc and Precarious: A Cautionary Note on Terlipressin in Early-Stage ACLF. Liver International, 45(12), e70456. [Link]
  23. Lei, Z. (2025). From Image to Insight: Is MRI-Based Genotyping Ready for the Clinic? Liver International, 45(7), e70193. [Link]
  24. Lei, Z. (2026). “One-time data, lifetime inference?” A caution on mediation in dysmenorrhea research. Journal of Affective Disorders, 393(Part A), 120350. [Link]
  25. Lei, Z. (2025). “High C-index, low events?” Reassessing AI claims in valve repair prediction. Journal of Thoracic and Cardiovascular Surgery. Advance online publication. [Link]
  26. Lei, Z. (2026). “Calibration or contamination?” Reassessing the evaluation of large language models for clinical mortality prediction. International Journal of Medical Informatics, 209, 106291. [Link]
  27. Lei, Z. (2025). “When less isn’t more” — Questioning prophylactic lymph node dissection in low-recurrence SPTCI. Oral Oncology, 168, 107594. [Link]
  28. Lei, Z. (2026). “Overfitting or insight?” Re-evaluating a blood-based machine learning model for high myopia. Eye. Advance online publication. [Link]
  29. Lei, Z. (2025). Shiny curves, shaky foundations: Bias and reliability in no-reflow prediction models. International Journal of Cardiology, 441, 133763. [Link]
  30. Lei, Z. (2025). Comment on “Effects of relaxation training combined with music-based intervention on anxiety and depression in patients undergoing hematopoietic stem cell transplantation: a quasi-experimental study”. Supportive Care in Cancer, 33, 1088. [Link]
  31. Lei, Z. (2025). “Data or Distraction?” Reassessing the Conclusions on Resident Involvement in Lung Cancer Surgery. European Journal of Cardio-Thoracic Surgery, 67(10), ezaf323. [Link]
  32. Lei, Z. (2026). Comment on “Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics During Breast Cancer Treatment”. Integrative Cancer Therapies, 25. [Link]
  33. Lei, Z. (2025). In Reference to Now You See It, Now You Don't: Laryngoscopy Findings of Paradoxical Vocal Fold Motion. The Laryngoscope, 135(12), E104–E105. [Link]
  34. Lei, Z. (2025). Letter to the Editor on “The Statistical Fragility of Randomized Controlled Trials in Kidney Stone Management: An Analysis of American Urological Association and European Association of Urology Guidelines”. Urology, 202, 56–57. [Link]
  35. Lei, Z. (2026). When Numbers Mislead: Reassessing Statistical Foundations in PCA-Based Prognostication of Fontan Outcomes. Cardiovascular Science, 3(1), 10015. [Link]

Conference Papers

  1. Lei, Z. (2024). Analysis of Simpson’s Paradox and Its Applications. Highlights in Science, Engineering and Technology, 88, 357–362. [Link]